03-15-2018 03:38 PM CET - Health & Medicine

Macrolide Antibiotics Market Outlook (2018-2024) by Top Industry Vendors Like Pfizer Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Bayer AG and More

Press release from: Data Bridge Market Research
Global Macrolide Antibiotics Market – Industry Trends and Forecast to 2024
Global Macrolide Antibiotics Market – Industry Trends and Forecast to 2024
Global Macrolide Antibiotics Market By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin), By Route of Administration (Oral, Parenteral), By Infection (Mycoplasma pneumoniae, Legionella sp., Or Bordetella pertussis,Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis, Uncomplicated Skin Infections), By End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Center, Research Laboratories), By Geography and Forecast to 2024.

Get Free Sample Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Global Macrolide Antibiotics Market accounted to grow at a CAGR of 12.7% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Competitive Analysis: Global Macrolide Antibiotics Market

The macrolide antibiotics market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of macrolide antibiotics market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors: Global Macrolide Antibiotics Market

Some of the major players operating in macrolide antibiotics market areMerck Co. & Inc., Pfizer Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Bayer AG, Abbott, Novartis AG, Sanofi, AstraZeneca, F. Hoffmann-La Roche AG, Cempra, Inc., Macrolide Pharmaceuticals, Inc., SM Biomed, Barkat Pharmaceutical Group, Active Pharmaceutical Ingredient Manufacturing, Mustafa NevzatİlaçSanayii A.Ş., Zhejiang Guobang Pharmaceutical Co., Ltd., Tianyin Pharmaceutical Co., Inc., Japan Pharmaceutical Manufacturers Association(JPMA) and Murli Krishna Pharma among others.

For More Details In-Depth Inquiry @ databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Market Definition: Global Macrolide Antibiotics Market

Macrolides are a class of antibiotics derived from Saccharopolyspora erythraea. They inhibit protein synthesis in bacteria by binding to the 50S ribosomal element and effective against gram positive bacteria and intracellular pathogens such as Legionella, Mycoplasma and Chlamydia. It primarily act as a bacteriostatic agent against many strains of Corynebacteria, listeria, Moxicella, streptococci, Neisseria meningitides, Staphylococci, Clostridia and Haemophilus sp.

Major market drivers and restraints:

Growth in skin infections.
Rise in demand of drugs against bacterial skin infections.
Macrolide antibiotics increase the risk of sudden cardiac death.
Market Segmentation: Global Macrolide Antibiotics Market
The global macrolide antibiotics market is segmented by drugs into azithromycin, clarithromycin, erythromycin, fidaxomicinand telithromycin.

On the basis of route of administration the market is segmented into oral and parenteral.

On the basis of indication the market is segmented into infection due to Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis,symptomatic cat-scratch disease, Bacillaryangiomatosis, Peliosishepatis in patients with AIDS, cerebral toxoplasmosis, uncomplicated skin infections and others.

On the basis of end user, the market is segmented into hospital, dermatology clinic, clinic, ambulatory center, research laboratories.

On the basis of geography, global macrolide antibiotics market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

View Full Report @ databridgemarketresearch.com/reports/global-macrolide-ant...

Related Report

Global Pen Needles Market – Industry Trends and Forecast to 2024

Global Pen Needles Market, By Product Type (Standard Pen Needles, Safety Pen Needles), By Product Length (Nano Length, Medium Length, Long length), By Usability (Reusable Pen Needles, Disposable Pen Needles), By Application (Diabetes, Growth Hormone Deficiency, Others), By Therapy (Insulin, Glucagon-like peptide-1, Growth Hormones), By End-User (Hospitals, Clinics, OTC, Home Healthcare, Others), By Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Industry Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/global-pen-needles-m...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com

This release was published on openPR.
News-ID: 980582 • Views: 446
More releasesMore releases

You can edit or delete your press release here: